Actavis
Sign in to saveActavis Generics (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.
Key facts
- Company.name
- Actavis Generics
- Company.logo
- Actavis-logo.svg
- Company.logo_size
- 200px
- Company.type
- Subsidiary
- Company.fate
- 2015 Irish tax inversion and merger with Allergan, Inc.
- Company.parent
- Teva Pharmaceuticals
- Company.successor
- Allergan, plc
- Company.foundation
- in Libertyville, Illinois, United States
- Company.founder
- Allen Chao, Ph.D. and David Hsia, Ph.D.
- Company.location
- Dublin, Ireland and Parsippany-Troy Hills, New Jersey, United States
- Company.locations
- 40 manufacturing facilities27 global R&D centers
- Company.area_served
- ≈100 countries
- Company.key_people
- Brenton L. Saunders (CEO and president) Paul Bisaro (executive chairman)
- Company.industry
- Branded and generic pharmaceuticals, and pharmaceutical research and development
- Company.products
- Branded and generic pharmaceuticals
- Company.revenue
- US$13.062 billion (2014)
- Company.operating_income
- US$1.090 billion (2014)
- Company.net_income
- (2014)
via Wikipedia infobox
Article
17 sectionsContents
- History
- Company evolution
- 1990s
- 2000 to 2009
- 2011 to 2014
- Actavis acquisition and Watson name change
- Warner Chilcott PLC acquisition
- Forest Laboratories acquisition
- Allergan Inc acquisition and Actavis PLC name change
- Locations and facilities
- Global headquarters
- Manufacturing facilities
- Research and development facilities
- United Kingdom price fixing charges
- In popular culture
- References
- External links
Actavis Generics (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.
Actavis markets brand products through six franchises in key therapeutic categories including: Aesthetics/Dermatology/Plastic Surgery; Neurosciences/CNS; Eye Care; Women's Health and Urology; GI and Cystic Fibrosis; and Cardiovascular Disease and Infectious Disease. The company's products include Botox, Namenda, Restasis, Linzess, Bystolic, Juvederm, Latisse, Lo Loestrin Fe, Estrace, Teflaro, Dalvance, Ozurdex, Optive, Natrelle, Viibryd, Liletta, Saphris, Enablex, Actonel, Androderm, Gelnique and others.
Connections
Categories
1984 establishments in Illinois2016 mergers and acquisitionsCompanies based in Morris County, New JerseyCompanies formerly listed on the New York Stock ExchangeGeneric drug manufacturersManufacturing companies based in Dublin (city)OpenCorporates groupingsOpen Government Licence attributionParsippany–Troy Hills, New JerseyPharmaceutical companies based in New JerseyPharmaceutical companies established in 1984